Cargando…

SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence

The SARS-CoV-2 virus is rapidly evolving via mutagenesis, lengthening the pandemic, and threatening the public health. Until August 2021, 12 variants of SARS-CoV-2 named as variants of concern (VOC; Alpha to Delta) or variants of interest (VOI; Epsilon to Mu), with significant impact on transmissibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatsi, Elizabeth-Barbara, Filippatos, Filippos, Michos, Athanasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632374/ https://www.ncbi.nlm.nih.gov/pubmed/34732275 http://dx.doi.org/10.1017/S0950268821002430

Ejemplares similares

Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
por: Filippatos, Filippos, et al.
Publicado: (2021)

Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence
por: Filippatos, Filippos, et al.
Publicado: (2023)

2369. kinetics of total and neutralizing SARS-CoV-2 spike antibodies after the 2nd and 3rd dose of the BNT162b2 covid-19 vaccine and association with epidemiological characteristics and breakthrough infection
por: Michos, Athanasios, et al.
Publicado: (2023)

Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement of SARS-CoV-2 spike protein antibody neutralizing activity
por: Filippatos, Filippos, et al.
Publicado: (2023)

Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2023)

Post‑COVID‑19 syndrome in children (Review)
por: Filippatos, Filippos, et al.
Publicado: (2022)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine
por: Michos, Athanasios, et al.
Publicado: (2021)

Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
por: Dourdouna, Maria-Myrto, et al.
Publicado: (2023)

Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
por: Michos, Athanasios, et al.
Publicado: (2022)

SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods
por: Tatsi, Elizabeth-Barbara, et al.
Publicado: (2021)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
por: Rabaan, Ali A., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
por: Rayati Damavandi, Amirmasoud, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Clinical Application of the Novel Cell-Based Biosensor for the Ultra-Rapid Detection of the SARS-CoV-2 S1 Spike Protein Antigen: A Practical Approach
por: Mavrikou, Sophie, et al.
Publicado: (2021)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development
por: Bostanghadiri, Narjess, et al.
Publicado: (2023)

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

904. Epidemiology of Rotavirus Group A Mixed Genotypes Isolated from Children with Acute Gastroenteritis over a 15-Year Period
por: Dellis, Charilaos, et al.
Publicado: (2023)

SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
por: Fayad, Nancy, et al.
Publicado: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2020)

Current advances in the development of SARS-CoV-2 vaccines
por: Awadasseid, Annoor, et al.
Publicado: (2021)

The conundrum of current anti-SARS-CoV-2 vaccines
por: Federico, Maurizio
Publicado: (2021)

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
por: Wang, Lisheng, et al.
Publicado: (2020)

Current evidence on pancreatic involvement in SARS-CoV-2 infection
por: Thaweerat, Wajana
Publicado: (2020)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
por: Wambani, Josephine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pb96mcp95peee0rppimhbdl6jh